Regeneron's COVID-19 drug effective in early disease stage
Company says it is discussing the positive preliminary drug trial results with regulators.
This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.
0 comments:
Post a Comment